Moody Lynn & Lieberson, LLC Iovance Biotherapeutics, Inc. Transaction History

Moody Lynn & Lieberson, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 30, 2020	SELL	$19.54 - $38.85 $1.4 Million - $2.79 Million	-71,735 Closed	0 $0
Q4 2019 Jan 28, 2020	BUY	$17.95 - $29.41 $1.04 Million - $1.71 Million	58,140 Added 427.66%	71,735 $1.99 Million
Q3 2019 Oct 28, 2019	SELL	$17.99 - $26.0 $581,976 - $841,100	-32,350 Reduced 70.41%	13,595 $247,000
Q2 2019 Jul 23, 2019	BUY	$9.78 - $24.52 $449,342 - $1.13 Million	45,945 New	45,945 $1.13 Million

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.35B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Moody Lynn & Lieberson, LLC, based on Form 13F filings with the SEC.

Stay updated on Moody Lynn & Lieberson, LLC with notifications on news.